The ScopioVet digital cytology system is now available commercially throughout the United States and Canada, manufacturer Scopio Labs reported.
The proprietary digital microscopy system uses an intuitive pathology consultation service and artificial intelligence to automate routine diagnostic tests, the company stated.
“To provide a conclusive diagnosis for the range of sample types our customers process, 100X magnification is the gold standard,” said Scopio Labs’ medical director, Natalie Hoepp, DVM, MS, DACVP. “Anything less will leave the clinical pathologist in doubt due to lack of finer microscopic detail, or worse, they may not be able to accurately identify certain microscopic features at all.”
ScopioVet is the highest-resolution system of its kind and provides fast results, the company reported.
“When veterinarians and pet parents wait several days for results to come back, as is the case in most veterinary practices worldwide, the value of cytology is reduced,” said Asher Fink, head of veterinary business and vice president of business development for Scopio Labs. “ScopioVet corrects this dynamic by providing results in less than an hour, unlocking the true value of cytology and improving the standard of care so veterinarians can deliver exceptional service with improved outcomes.”
Scopio Labs is headquartered in Israel and maintains an office in New Jersey.
Did you know a subscription to Today’s Veterinary Business is free to qualified veterinary professionals?